Skip to search.
 TSX Up 0.38% TSX Ventures Down 0.06%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
1.68 Up 0.05(3.07%) 4:00PM EST
|After Hours : 1.68 0.00 (0.00%) 4:39PM EST - Nasdaq Real Time Price
Prev Close:1.63
Open:1.64
Bid:1.50 x 500
Ask:1.70 x 4700
1y Target Est:5.00
Beta:2.66402
Next Earnings Date:N/A
Day's Range:1.55 - 1.69
52wk Range:1.19 - 4.14
Volume:1,386,526
Avg Vol (3m):1,658,570
Market Cap:248.06M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
IDRAUp 3.07%248.06M
PFEDown 0.80%187.76B
DVAXDown 4.00%184.93M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):217.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.42
Quarterly EPS Est (Dec-16) :-0.11
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback